Related Content
June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...
June 3, 2025 — Bayer announced it will present multiple new analyses of the Kerendia (finerenone) clinical trial program ...
March 25, 2025 — Bayer plans to present data from 13 new analyses from across the KERENDIA (finerenone) comprehensive ...
March 17, 2025 — Bayer recently announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental new ...
May 17, 2024 — The study design and baseline characteristics of FINE-HEART, a new prespecified, exploratory pooled ...
April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...
March 29, 2020 — Patients with worsening heart failure and reduced ejection fraction who received the investigational ...
July 15, 2019 — The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic ...
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
August 29, 2017 — The European Medicines Agency (EMA) issued a final opinion that recommended restricting the use of ...